US EditionPublished • loading... • Updated
Spotlighting Sequencing and Biomarkers in Bladder Cancer Management | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Summary by targetedonc.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Spotlighting Sequencing and Biomarkers in Bladder Cancer Management | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
During his presentation at the 4th Annual Miami Cancer Institute Precision Oncology Symposium, Petros Grivas, MD, PhD, FASCO, provided a detailed roadmap for community oncologists with an emphasis on precision medicine.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
